Titan Reports Patient Enrollment In Phase III Study Of Probuphine� Is Ahead...
Titan Pharmaceuticals, Inc. (OTC Bulletin Board: TTNP) announced that patient enrollment is more than 60% complete in the confirmatory Phase 3 clinical study of Probuphine for the treatment of opioid...
View ArticleNarconon Fresh Start Launches Efforts to Educate Parents about the Dangers in...
Many young people are intentionally abusing schedule 2 medications and going on to develop drug and alcohol addiction problems as they grow up. Narconon Fresh Start is launching a new division of...
View ArticleREEL Recovery Film Festival – SF Bay Area Weekend Schedule Filled With World...
Alcohol Justice logo. (PRNewsFoto/Alcohol Justice) SAN FRANCISCO, April 26, 2014 /Emag.co.uk/ – San Rafael-based Alcohol Justice and Studio City-based Writers In Treatment say some of… via Emag.co.uk...
View Article
More Pages to Explore .....